Modern lineages of Mycobacterium tuberculosis were recently introduced in western India and demonstrate increased transmissibility

Avika Dixit, Anju Kagal, Yasha Ektefaie, Luca Freschi, Rajesh Karyakarte, Rahul Lokhande, Matthias I. Gröschel, Jeffrey A. Tornheim, Nikhil Gupte, Neeta Pradhan, Mandar Paradkar, Sona Deshmukh, Dileep Kadam, Marco Schito, David M. Engelthaler, Amita Gupta, Jonathan E. Golub, Vidya Mave, Maha FarhatmedRxiv 2022 · DOI

TL;DR

By applying whole-genome sequencing to Mycobacterium tuberculosis (Mtb) isolates in Western India, researchers found that "modern" lineages (L2 and L4) are spreading more aggressively and carrying higher rates of drug resistance than native "ancient" lineages. These findings suggest that these newer variants may eventually displace older ones, complicating tuberculosis control efforts in one of the world's highest-burden regions.

What Problem Does This Paper Address?

Tuberculosis (TB) remains a leading infectious killer globally, and its decline in incidence has been stubbornly slow. One hypothesis is that certain lineages of Mtb are more "fit"—meaning they transmit more easily or acquire drug resistance more readily.

In India, which carries a quarter of the global TB burden, the "ancient" Lineage 1 (L1) has historically predominated. However, "modern" lineages like L2 (Beijing) and L4 (Euro-American) are increasingly common. The authors sought to determine if these modern lineages are actually more transmissible in the Indian context and how their introduction has impacted the landscape of drug resistance.

Methods

The researchers analyzed 612 high-quality Mtb isolates collected from two prospective cohort studies in Pune, India, between 2013 and 2018. Their approach combined several advanced genomic techniques:

  • Whole-Genome Sequencing (WGS): Used to overcome the limitations of traditional molecular typing (like spoligotyping), which often misses fine-scale genetic variation.
  • Genotypic Resistance Prediction: They used a validated Random Forest machine learning model to predict resistance to 13 antibiotics based on 992 genetic variants.
  • Phylogenetic Analysis: They built evolutionary trees using Maximum Likelihood estimation and used Bayesian molecular dating (BEAST) to estimate the age of different branches.
  • Transmissibility Metrics: They used "terminal branch lengths" as a proxy for transmission speed. Shorter branches indicate less time (and fewer mutations) between transmission events.
  • Propensity to Propagate (PTP): A method used to control for host-related factors (like age or HIV status) to ensure the observed transmission differences were due to the bacteria, not just the patients.

Datasets

The study utilized isolates and clinical data from two major sources in Pune, Maharashtra:

  1. CTRIUMPH: A prospective observational study of active TB and household contacts.
  2. TB-Diabetes Study: A cohort focused on the interaction between TB and diabetes mellitus.
  3. Reference Genome: H37Rv (GenBank NC000962.3) was used as the outgroup for phylogenetic mapping.

Key Insights and Ideas

  • The "Modern" Advantage: Lineages 2 and 4 showed significantly shorter terminal branch lengths and more recent branching times than L1 and L3. This suggests they were introduced to the region relatively recently but are spreading much faster.
  • L2 as a Resistance Reservoir: While Lineage 2 (Beijing) made up only 7.3% of the total isolates, it accounted for a staggering 61.1% of all multidrug-resistant (MDR) cases.
  • Evolutionary Speed: The study found that L2 had a higher frequency of "resistance acquisition events." Essentially, L2 isn't just carrying resistance; it appears to be evolving new resistance faster than other lineages.
  • Displacement Risk: The data suggests a "future displacement" of native Indian lineages (L1 and L3) by these more transmissible, drug-resistant modern variants.
  • Discordance in Testing: The researchers found significant discrepancies between genotypic (DNA-based) and phenotypic (culture-based) drug susceptibility testing. Genotypic methods caught several resistant cases that traditional lab tests missed, highlighting the need for WGS in clinical surveillance.

Key Results

  • Transmissibility: Median terminal branch lengths for L2 were 3.3 SNS (single nucleotide substitutions) compared to 7.8 SNS for L3 (p < 0.001), indicating much higher transmissibility for L2.
  • Clustering: Isolates belonging to L2 and L4 had 2 to 3 times the odds of being part of a transmission cluster compared to L1, even after adjusting for host factors.
  • MDR Prevalence: 24.4% of L2 isolates were multidrug-resistant, compared to only 0.6% of L1 and 1.5% of L3.
  • Introduction Timing: Molecular dating confirmed that L2 and L4 are "recent" arrivals in Western India compared to the "ancient" L1 and L3.

Limitations and Future Work

The authors acknowledge that they used a convenience sample of patients seeking care, which might miss some transmission links in the community. Additionally, WGS typically misses about 10% of the Mtb genome (repetitive regions), which could lead to an underestimation of genetic distances.

Future work is needed to expand this surveillance across other regions of India to see if this "modern displacement" is a national trend. The authors also emphasize the urgent need for contact tracing specifically around L2 cases to interrupt these high-speed transmission chains.

Summary updated

Abstract

Abstract Background Mycobacterium tuberculosis ( Mtb ) transmissibility may vary between lineages (or variants) and this may contribute to the slow decline of tuberculosis (TB) incidence. The objective of our study was to compare transmissibility across four major lineages (L1-4) of Mtb among participants from two cohort studies in Pune, India. Methods We performed whole-genome sequencing (WGS) of Mtb sputum culture-positive isolates from participants in two prospective cohort studies of adults with pulmonary TB seeking care at public treatment centers in Pune, Maharashtra. We performed genotypic susceptibility prediction for both first- and second-line drugs using a previously validated random forest model. We used single nucleotide substitutions (SNS) and maximum likelihood estimation to build isolate phylogenies by lineage. We used Bayesian molecular dating to estimate ancestral node ages and compared tree characteristics using a two-sample Kolmogorov-Smirnov (KS) test. Results Of the 642 isolates from distinct study participants that underwent WGS, 612 met sequence quality criteria. The median age of the 612 participants was 31 years (IQR 24.4-44.2), the majority were male (64.7%) and sputum smear-positive (83.3%), and 6.7% had co-infection with HIV. Most isolates belonged to L3 (44.6%). The majority (61.1%) of multidrug-resistant isolates (MDR, resistant to isoniazid and rifampin) belonged to L2 ( P &lt; 0.001 [Fisher’s Exact]). There was no significant difference in host characteristics between participants infected with the four major lineages. In phylogenetic analysis, we measured shorter terminal branch lengths in the L2 tree compared to L1 and L3 trees indicating less time elapsing between transmission and sampling and higher transmissibility (median branch lengths: L2 - 3.3, L3 - 7.8, p &lt;0.001). Branching times for L2 and L4 were more recent than L1 and L3 indicating recent introduction into the region (p &lt; 0.01 [KS test]). Conclusion Modern Mtb lineages (L2 and L4) were more recently introduced in western India, compared to older lineages (L1 and L3). L2 shows a higher frequency of drug-resistance and higher transmissibility. Our findings highlight the need for contact tracing around cases of TB due to L2, and heightened surveillance of TB antibiotic resistance in India.
BibTeX
@misc{dixit2022modern,
  author = {Avika Dixit and Anju Kagal and Yasha Ektefaie and Luca Freschi and Rajesh Karyakarte and Rahul Lokhande and Matthias I. Gröschel and Jeffrey A. Tornheim and Nikhil Gupte and Neeta Pradhan and Mandar Paradkar and Sona Deshmukh and Dileep Kadam and Marco Schito and David M. Engelthaler and Amita Gupta and Jonathan E. Golub and Vidya Mave and Maha Farhat},
  title = {{Modern lineages of <i>Mycobacterium tuberculosis</i> were recently introduced in western India and demonstrate increased transmissibility}},
  year = {2022},
  doi = {10.1101/2022.01.04.22268645},
  howpublished = {medRxiv},
}
Figure